Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Sociedade Hospital Samaritano | OTHER |
| D'Or Institute for Research and Education | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
CHECKLIST-ICU will be a cluster randomized trial to ascertain whether the use of an intervention including 1) checklists with assessment of daily goals during the multidisciplinary visit, and 2) clinician prompting can reduce in-hospital mortality of patients admitted to intensive care units (ICUs).
The investigators also aim to describe participant ICUs in terms of the standards for intensive care units proposed by the Brazilian National Health Agency (ANVISA).
Cluster randomized trial involving ICUs in Brazil. ICU is the unit of randomization.
The trial will have two stages:
Stage I - Baseline data.In this stage we will:
Stage II - Intervention: This is the main stage for data analysis. ICUs will be randomly assigned to an experimental or control group. The experimental group should use a multi-item verbal checklist including assessment of daily goals during the multidisciplinary visits plus clinician prompting. We will collect data from 60 additional patients for each ICU in both study groups and apply "Safety Attitudes Questionnaire".
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Daily checklist and clinician prompting | Experimental | Checklist during multidisciplinary daily visits + clinician prompting + audit & feedback |
|
| Usual care | No Intervention | Usual care |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Daily checklist and clinician prompting | Behavioral | Interventions are: Checklists: The checklists are arranged in a paper notebook (one per patient) with a daily list on each page, as most ICUs do not have electronic health record systems. During the multidisciplinary visit, the checklist items are read aloud by the nurse and answered by participants of the visit. The checklist is applied at least once on all week days preferably in the mornings, although we strongly suggest applying it also on weekend days. Daily Goals and Clinician Prompting: During the clinical discussion of each patient and the application of the checklist, the intensivists write down the daily goals in a standardized form and read them aloud to the team. Every afternoon between 3 and 5 PM, a nurse reviews the daily goals and takes note of any pending items. Subsequently, the nurse prompts the on-call physician, requesting solutions for these pending items. |
| Measure | Description | Time Frame |
|---|---|---|
| In-hospital mortality truncated at 60 days | Follow-up will be limited to 60 days after ICU admission. Patients who are still in the hospital after 60 days of ICU admission will be considered as discharged alive. | Hospital discharge; average of 20 days; follow-up limited to 60 days |
| Measure | Description | Time Frame |
|---|---|---|
| Head of the bed elevated at 30° | Every 3 three days, from ICU day 2 to 17 | |
| Adequate prophylaxis for venous thromboembolism | Every 3 three days, from ICU day 2 to 17 | |
Not provided
Inclusion criteria for clusters:
Exclusion criteria for clusters:
• We will exclude ICUs that systematically apply checklists in the multiprofessional daily visit. We define systematically applied checklist when all the following criteria are met:
Patient inclusion criteria:
• Adult patients (≥18 years-old) with anticipated ICU length of stay > 24 hours.
Patient exclusion criteria;
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Alexandre B Cavalcanti, MD, PhD | Research Institute - Hospital do Coracao | Study Chair |
| Fernando Bozza, MD, PhD | D'Or Institute for Research and Education | Principal Investigator |
| Jorge I Salluh, MD, PhD | D'Or Institute for Research and Education | Principal Investigator |
| Flávia Machado, MD, PhD | Federal University of São Paulo | Principal Investigator |
| Edson R Romano, MD | Hospital do Coracao | Principal Investigator |
| Karina Normilio-Silva | Research Institute - Hospital do Coração | Principal Investigator |
| Otavio Berwanger, MD, PhD | Research Institute - Hospital do Coracao | Principal Investigator |
| Patricia Vendramim, R.N. | Hospital Samaritano | Principal Investigator |
| Viviane C Chiattone, RN | Research Institute - Hospital do Coracao | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Alexandre Biasi Cavalcanti | São Paulo | São Paulo | 04005000 | Brazil |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 27115264 | Derived | Writing Group for the CHECKLIST-ICU Investigators and the Brazilian Research in Intensive Care Network (BRICNet); Cavalcanti AB, Bozza FA, Machado FR, Salluh JI, Campagnucci VP, Vendramim P, Guimaraes HP, Normilio-Silva K, Damiani LP, Romano E, Carrara F, Lubarino Diniz de Souza J, Silva AR, Ramos GV, Teixeira C, Brandao da Silva N, Chang CC, Angus DC, Berwanger O. Effect of a Quality Improvement Intervention With Daily Round Checklists, Goal Setting, and Clinician Prompting on Mortality of Critically Ill Patients: A Randomized Clinical Trial. JAMA. 2016 Apr 12;315(14):1480-90. doi: 10.1001/jama.2016.3463. | |
| 26017129 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Patient-days under light sedation or alert and calm (RASS - 3 to 0) |
| Every 3 three days, from ICU day 2 to 17 |
| Rate of central-line catheter use | Daily from ICU day 2 to 17 |
| Indwelling urinary catheter use rate | Daily from ICU day 2 to 17 |
| Rate of patients receiving enteral or parenteral feeding | Every 3 three days, from ICU day 2 to 17 |
| Tidal volume <=8mL/kg of predicted body weight in patients on mechanical | Every 3 three days, from ICU day 2 to 17 |
| ICU mortality | Follow-up will be limited to 60 days after ICU admission. Patients who are still in the ICU after 60 days of ICU admission will be considered as discharged alive. | ICU discharge; follow-up limited to 60 days |
| Central line-associated bloodstream infection (CLABSI) rate | Following the Centers for Disease Control/National Healthcare Safety Network (CDC/NHSN) Surveillance Definition of Healthcare-Associated Infection 2008 | Daily from ICU day 2 to 17 |
| Urinary tract infection associated with catheter rate | Daily from ICU day 2 to 17 |
| Ventilator-associated pneumonia (VAP) | Daily from ICU day 2 to 17 |
| Length of ICU stay | Follow-up will be limited to 60 days after ICU admission. Patients who are still in the hospital after 60 days of ICU admission will be considered as discharged alive. | Hospital discharge; follow-up limited to 60 days |
| Length of hospital stay | Follow-up will be limited to 60 days after ICU admission. Patients who are still in the hospital after 60 days of ICU admission will be considered as discharged alive. | Hospital discharge; average of 20 days; follow-up limited to 60 days |
| Mechanical ventilation-free days at 28 days | Survival time free of invasive mechanical ventilation from ICU admission to day 28. Patients who were discharged from hospital alive before 28 days are considered to be alive and free of mechanical ventilation until the 28th day. | Day 28 after ICU admission |
| Safety Attitudes Questionnaire Score | Survey | In phase 1, between sept/2013 and january/2014 each ICU staff answered the questionnaire once. In phase 2, between july/2014 and december/2014 the questionnaire was applied again (once for each ICU staff). |
| Helio P Guimaraes, MD, PhD | Research Institute - Hospital do Coracao | Principal Investigator |
| Valquiria P Campagnucci, MD | Research Institute - Hospital do Coracao | Principal Investigator |
| Derek C Angus, MD, PhD | Department of Critical Care Medicine and CRISMA Center. University of Pittsburgh School of Medicine | Principal Investigator |
| Fernanda Carrara, RN | Latin American Sepsis Institute (LASI) | Principal Investigator |
| Juliana Lubarino, RN | Latin American Sepsis Institute (LASI) | Principal Investigator |
| Aline R Sila, RN | D'Or Institute for Research and Education | Principal Investigator |
| Grazielle Viana, RN | D'Or Institute for Research and Education | Principal Investigator |
| Lucas P Damiani, MSc | Research Institute - Hospital do Coracao | Principal Investigator |
| Chung C Chang, PhD | Division of General Internal Medicine at University of Pittsburgh | Principal Investigator |
| Derived |
| Damiani LP, Cavalcanti AB, Moreira FR, Machado F, Bozza FA, Salluh JI, Campagnucci VP, Normilio-Silva K, Chiattone VC, Angus DC, Berwanger O, Chou H Chang C. A cluster-randomised trial of a multifaceted quality improvement intervention in Brazilian intensive care units (Checklist-ICU trial): statistical analysis plan. Crit Care Resusc. 2015 Jun;17(2):113-21. |
| 25928627 | Derived | CHECKLIST-ICU Investigators and BRICNet; Machado F, Bozza F, Ibrain J, Salluh F, Campagnucci VP, Guimaraes HP, Normilio-Silva K, Chiattone VC, Vendramim P, Carrara F, Lubarino J, da Silva AR, Viana G, Damiani LP, Romano E, Teixeira C, da Silva NB, Chang CC, Angus DC, Berwanger O. A cluster randomized trial of a multifaceted quality improvement intervention in Brazilian intensive care units: study protocol. Implement Sci. 2015 Jan 13;10:8. doi: 10.1186/s13012-014-0190-0. |